Optimi Health Corp. OPTH
Annual
Quarterly
No annual revenue total was found in Optimi Health Corp.'s SEC filings.
Optimi Health Corp. (OPTH) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OPTH (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC CIK
- 2027329
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 20, 2026 | Oct 20, 2026 |
| 6-K | Current report (foreign issuer) | Oct 7, 2026 | Oct 7, 2026 |
| 6-K | Current report (foreign issuer) | Sep 29, 2026 | Sep 29, 2026 |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 22, 2026 | Sep 22, 2026 |
All 47 Optimi Health Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.